Aboleris Pharma is a preclinical stage company, developing novel and unique therapeutic approaches to induce immune tolerance while preserving useful immune responses; with the aim to address significant medical unmet needs in patients with inflammatory, autoimmune and degenerative diseases.
Location: Belgium, Gosselies
Sound Contact: Bibhash Mukhopadhyay (Board Director) and Thomas Tan (Board Observer)
Read an interview with CEO Anne Meulemans
Web: https://aboleris-pharma.com
